Astrazeneca (AZN) EBT Margin (2009 - 2026)
Astrazeneca (AZN) reported EBT Margin of 18.19% for Q2 2026, down 3.44 percentage points from 21.63% a year earlier and down 7.41 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) EBT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Astrazeneca's EBT Margin came in at 39.20%, up 21.46 percentage points year-over-year; for FY2025, it came in at 21.11%, up 5.04 percentage points from FY2024.
- EBT Margin has increased for four consecutive years, with a five-year change of +6.40 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at 16.07% in FY2024 (+1.01 pp), 15.06% in FY2023 (+9.42 pp), 5.64% in FY2022 (+6.35 pp) and -0.71% in FY2021 (-15.42 pp).
- The Q2 2026 figure ranks as the lowest quarterly EBT Margin since Q4 2024.
- Year over year, EBT Margin gained in six of the last eight quarters, with an average year-over-year change of +11.71 percentage points.
- The high point for year-over-year EBT Margin in five years was Q4 2025 (a gain of 79.77 percentage points); the low point was Q3 2021 (a drop of 33.25 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 25.60% (Q1 2026), 90.96% (Q4 2025) and 21.35% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 41.75% |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 31.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.19% |
| Mar 31, 2026 | 25.60% |
| Dec 31, 2025 | 90.96% |
| Sep 30, 2025 | 21.35% |
| Jun 30, 2025 | 21.63% |
| Mar 31, 2025 | 25.04% |
| Dec 31, 2024 | 11.19% |
| Sep 30, 2024 | 13.48% |
| Jun 30, 2024 | 18.53% |
| Mar 31, 2024 | 22.08% |
| Dec 31, 2023 | 7.46% |
| Sep 30, 2023 | 14.38% |
| Jun 30, 2023 | 18.29% |
| Mar 31, 2023 | 20.79% |
| Dec 31, 2022 | 6.94% |
| Sep 30, 2022 | 8.40% |
| Jun 30, 2022 | 2.29% |
| Mar 31, 2022 | 4.86% |
| Dec 31, 2021 | -5.30% |
| Sep 30, 2021 | -20.28% |
API Access
Astrazeneca EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();